p53 Gene mutations in superficial bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Superficial bladder tumors, specifically transitional cell carcinoma (TCC), present a risk for recurrence and progression.
• The p53 tumor suppressor gene plays a critical role in cell cycle regulation and apoptosis.
• Understanding p53 gene mutations in TCC is crucial for assessing cancer prognosis.

Purpose of the Study:

• To investigate the prevalence of p53 gene mutations in superficial TCC.
• To determine the association between p53 mutations and established prognostic factors for bladder cancer.
• To analyze the impact of these mutations on P53 protein structure and function.

Main Methods:

• An observational, cross-sectional study involving 90 patients (60 with superficial TCC, 30 controls).
• Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) was used to detect p53 mutations in exons 5-9.
• Automatic sequencing identified mutation characteristics and their effects on P53 protein structure, with bivariate analysis for prognostic factors.

Main Results:

• No p53 mutations were found in the control group; 38.3% of superficial TCC patients exhibited mutations.
• All detected mutations were point mutations, with 86.67% impacting P53 structure, often in conserved regions or mutational hotspots.
• Higher cell differentiation grades and pT1 stage were linked to increased p53 mutation incidence.

Conclusions:

• p53 gene mutations are absent in healthy bladder mucosa and significantly more prevalent in high-grade (G-II/G-III) and pT1 stage superficial TCC.
• The majority of detected point mutations caused substantial P53 structural abnormalities, likely affecting its function.
• While not linked to all classic prognostic factors, specific p53 mutations may hold prognostic significance in superficial bladder cancer, warranting further investigation.